<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03936530</url>
  </required_header>
  <id_info>
    <org_study_id>MISC- Infrapyloric LNM</org_study_id>
    <nct_id>NCT03936530</nct_id>
  </id_info>
  <brief_title>Infrapyloric and Greater Curvature Lymph Node Metastasis in Colon Cancer</brief_title>
  <official_title>Infrapyloric (No.206) and Greater Curvature (No.204) Lymph Node Metastasis in Adenocarcinoma Located at Hepatic Flexure and Right Half of Transverse Colon</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Minimally Invasive Surgery Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai Minimally Invasive Surgery Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The infrapyloric (No.206) and greater curvature (No.204) lymph node metastasis in&#xD;
      adenocarcinoma located at hepatic flexure and right half of transverse colon has not been&#xD;
      well discribed and analysed. The aim of this study is to assess the rate of this lymph node&#xD;
      metastasis and to reveal its prognostic value for colon cancer located at hepatic flexure and&#xD;
      right half of transverse colon. Meanwhile, we can evaluate the safety and feasibility of this&#xD;
      extented lymphadenectomy in right hemi-colectomy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 20, 2019</start_date>
  <completion_date type="Anticipated">April 2025</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>metastasis rate</measure>
    <time_frame>an average of 1 year</time_frame>
    <description>metastasis rate of infrapyloric (No.206) and greater curvature (No.204) lymph node</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>lymphadenectomy time</measure>
    <time_frame>an average of 1 year</time_frame>
    <description>time of lymphadenectomy of infrapyloric (No.206) and greater curvature (No.204) lymph node</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>intraoperative complication</measure>
    <time_frame>an average of 1 year</time_frame>
    <description>intraoperative complication</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative complication</measure>
    <time_frame>an average of 1 year</time_frame>
    <description>postoperative complication</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>3-year DFS</measure>
    <time_frame>an average of 3 years</time_frame>
    <description>3-year disease free survival</description>
  </secondary_outcome>
  <enrollment type="Anticipated">427</enrollment>
  <condition>Colorectal Neoplasm</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients hospitalized in Shanghai Minimally Invasive Surgery Center&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age between 18 and 75 years&#xD;
&#xD;
          -  American Society of Anesthesiologists (ASA) score I to III&#xD;
&#xD;
          -  A biopsy proven histological diagnosis of colorectal carcinoma&#xD;
&#xD;
          -  tumor located at hepatic flexure and right half of transverse colon&#xD;
&#xD;
          -  Undergoing right hemi-colectomy with extented lymphadenectomy of infrapyloric (No.206)&#xD;
             and greater curvature (No.204) lymph node&#xD;
&#xD;
          -  Preoperative staging cT2-4aN0M0 or cTanyN+M0&#xD;
&#xD;
          -  Willing to participate and informed consent signed&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant or lactating women&#xD;
&#xD;
          -  Synchronous colorectal carcinoma&#xD;
&#xD;
          -  History of colorectal cancer or other malignant tumors&#xD;
&#xD;
          -  Clinical evidence of metastasis&#xD;
&#xD;
          -  Preoperative staging cT1N0 or cT4bNany&#xD;
&#xD;
          -  Emergency procedure&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Zhenghao CAI, MD</last_name>
    <phone>+862164458887</phone>
    <email>c3z2h1@alumni.sjtu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ruijin hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200025</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhenghao Cai, MD</last_name>
      <phone>+8617316533505</phone>
      <email>c3z2h1@alumni.sjtu.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>May 2, 2019</study_first_submitted>
  <study_first_submitted_qc>May 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 3, 2019</study_first_posted>
  <last_update_submitted>April 4, 2021</last_update_submitted>
  <last_update_submitted_qc>April 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>colon adenocarcinoma</keyword>
  <keyword>lymph node metastasis</keyword>
  <keyword>right hemi-colectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Lymphatic Metastasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

